Image – Interventional flashlight

DOI: 10.4244/EIJ-D-20-00427

Intravascular ultrasound guidance for valve-in-valve transcatheter pulmonary valve replacement

Łukasz Kalińczuk1, MD; Michał Świerczewski1; Gary S. Mintz2, MD; Marcin Demkow1, MD

Figure 1. Corresponding angiography and IVUS images of the RVOT anatomy, obtained sequentially during the intentional fracture of a 23 mm diameter Magna bioprosthesis (using an Atlas GOLD 24 mm at 18 atm) prior to valve-in-valve transcatheter pulmonary valve replacement with a 22 mm diameter Melody pulmonary valve.

A 28-year-old male with tetralogy of Fallot underwent total correction at the age of five with a transannular patch of the pulmonary valve. Fifteen years later, he had a 23 mm diameter Magna bioprosthesis (Edwards Lifesciences, Irvine, CA, USA) inserted at the pulmonary position due to pulmonary valve insufficiency. He was scheduled for valve-in-valve transcatheter pulmonary valve replacement (TPVR) due to symptomatic bioprosthesis dysfunction (insufficiency and stenosis).

Intravascular ultrasound (IVUS) (Visions PV .035 Digital Catheter; Philips Volcano, San Diego, CA, USA) visualised right ventricle outflow tract (RVOT) cross-sections (Baseline IVUS corresponding to Baseline ANGIO #1-5 in Figure 1) revealing immobile cusps with a narrowed valve orifice (86.2 mm2, #2) and permitting an excellent insight into the structure of the bioprosthesis posts (#2) and ring (#3-4). RVOT dimensions above the bioprosthesis stent posts were 26.7×28.7 mm (#1), with inner ring diameters of 19.4×20.2 mm (#4) and outer ring diameters of 23.4×23.7 mm. IVUS also visualised the 26.8×27 mm native annulus outside of the ring (#4). RVOT, just beneath the valve ring, was elliptical with an area of 635.5 mm2 (derived diameter of 28.4 mm) (#5).

The Magna frame was fractured using an Atlas® GOLD 24 mm at 18 atm (Bard Peripheral Vascular, Tempe, AZ, USA), with a subsequent increase in valve frame dimensions (Fracture panel; black arrow indicates the fracture site) and bioprosthesis post motion (Fracture panel; white arrow indicates the stent’s post) to 22.8×24.5 mm (399.5 mm2, Serial IVUS panel, column #4). A 36 mm bare metal stent (IntraStent™ LD Max; ev3, Plymouth, MN, USA) was deployed on a 24 mm balloon-in-balloon catheter (BIB®; NuMED, Hopkinton, NY, USA, Post-stent panel). IVUS verified stent expansion, oval shape, and stent inner diameters of 21.8×22.5 mm (354.7 mm2, Serial IVUS panel, column #4). A Melody™ pulmonary valve (Medtronic, Minneapolis, MN, USA) was deployed on a 22 mm Ensemble® transcatheter delivery system (Medtronic) (Post Melody panel). IVUS verified inner valve diameters of 20.9×21.3 mm (348.0 mm2, Serial IVUS panel, column #4). After post-dilation with an Atlas GOLD 24 mm at 16 atm, IVUS inner valve frame dimensions increased to 21.8×23.1 mm (358.7 mm2) with symmetrical leaflet motion (Serial IVUS panel, column #4). There was no RVOT gradient.

Conflict of interest statement

G.S. Mintz has received honoraria from Boston Scientific, Philips, Medtronic, and Terumo (but none allied to the current manuscript). M. Demkow is proctoring for Medtronic. The other authors have no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Volume 16 Number 14
Feb 19, 2021
Volume 16 Number 14
View full issue


Key metrics

On the same subject

10.4244/EIJV13I9A155 Oct 11, 2017
“Breaking the code” of small bioprosthetic surgical valves
Codner P and Kornowski R
free

10.4244/EIJV14I13A243 Jan 18, 2019
Why we need another percutaneous pulmonary valve: if size matters
Lurz P and Kister T
free

EXPERT REVIEW

10.4244/EIJ-D-17-00501 Sep 24, 2017
Percutaneous pulmonary valve implantation: what have we learned over the years?
Boudjemline Y
free

State-of-the-Art Review

10.4244/EIJ-D-21-00157 Oct 20, 2021
Transcatheter aortic valve implantation in degenerated surgical aortic valves
Tarantini G et al
free

10.4244/EIJV14I9A174 Oct 12, 2018
A tune of triumph
Schmid M and Vejlstrup N
free
Trending articles
338.03

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
284.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved